Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors | Patent Number 09840491

US 09840491 B2
Application Number15015571
Publication NumberUS 20160229833 A1
Pendency1 year, 10 months, 12 days
Filled DateFeb 4, 2016
Priority DateFeb 5, 2015
Publication DateAug 11, 2016
Expiration DateFeb 4, 2035
Inventor/ApplicantsAdam Charles Talbot
Ann-Marie Campbell
Alexandre Joseph Buckmelter
David R. Lancia, Jr.
Stephanos Ioannidis
Minghua Wang
Bruce Follows
David Lancia, JR.
ExaminesWARD, PAUL V
Art Unit1624
Technology Center1600
Assignments
Valo Health Inc.
Current
Forma Therapeutics Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.